Announcements Trials

Browse Landscape

Phase

Phase NA 11 Phase 2 4 Phase 4 2 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 6 CNS 5 Plasma cell 4 Other solid neoplasm 2 Other hematologic neoplasm 2 Lymphoid 2 Gastrointestinal 2 Sarcoma 1 Gynecologic 1 Genitourinary 1 Dermatologic 1 Breast 1

Conditions

Prostatic Neoplasms 657 Carcinoma, Renal Cell 385 Carcinoma, Non-Small-Cell Lung 243 Urinary Bladder Neoplasms 235 Breast Neoplasms 221 Melanoma 193 Ovarian Neoplasms 192 Neoplasms 178 Colorectal Neoplasms 161 Kidney Neoplasms 152 Neoplasm Metastasis 131 Carcinoma, Transitional Cell 127 Pancreatic Neoplasms 124 Lung Neoplasms 121 Stomach Neoplasms 114 Squamous Cell Carcinoma of Head and Neck 107 Sarcoma 99 Head and Neck Neoplasms 89 Uterine Cervical Neoplasms 88 Carcinoma, Hepatocellular 80 Triple Negative Breast Neoplasms 76 Esophageal Neoplasms 76 Endometrial Neoplasms 75 Colonic Neoplasms 64 Wilms Tumor 56 Small Cell Lung Carcinoma 55 Carcinoma, Ovarian Epithelial 48 Neuroblastoma 47 Liver Neoplasms 46 Testicular Neoplasms 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Disease Progression × Genitourinary × Clear all

NCT01692262 2014-06-19

PYRUS

AstraZeneca

Phase 1 Completed

Prostatic Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡